Promising antidiabetic drug

We have started an interesting study with a promising antidiabetic drug. The drug is designed in the form of prolonged-action tablets, which action leads to increased insulin secretion. It is an innovative drug that is in the first phase of research when it is first used in humans. The first drug administrations are behind us, we continue with the next doses. We plan to complete 1 part of SAD (single ascending dose) at the end of July.

More and more people are suffering from type II diabetes, it is a civilization disease, we challenge it with new drugs in the hope of full success. The BRG Center hopes to participate in many such Polish projects.

Go back

News

Medical Guide Where to Treat 2022

On 29th of April, a special thematic supplement was published in the Polska The Times and Miasto.pl newspaper - Medical Guide Where to Treat 2022...

Read more …

BRG Support for Ukraine

We are deeply moved and concerned by the events in Ukraine. As a clinical site, focused on the development of medicine and helping other people,...

Read more …

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

Read more …

GcLP quality certificate for laboratory procedures

The BRG Clinical Site received the GcLP quality certificate for laboratory procedures and is in the process of obtaining GMP certification for pharmaceutical procedures.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2022 © Bio Research Group. All rights reserved.

 

scroll to top ▲